JP2005529082A - 9−デオキソ−9a−アザ−9a−メチル−9a−ホモエリスロマイシンA等構造擬似多形 - Google Patents

9−デオキソ−9a−アザ−9a−メチル−9a−ホモエリスロマイシンA等構造擬似多形 Download PDF

Info

Publication number
JP2005529082A
JP2005529082A JP2003575884A JP2003575884A JP2005529082A JP 2005529082 A JP2005529082 A JP 2005529082A JP 2003575884 A JP2003575884 A JP 2003575884A JP 2003575884 A JP2003575884 A JP 2003575884A JP 2005529082 A JP2005529082 A JP 2005529082A
Authority
JP
Japan
Prior art keywords
deoxo
aza
homoerythromycin
methyl
pseudopolymorph
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2003575884A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005529082A5 (cg-RX-API-DMAC10.html
Inventor
デュミック,ミリエンコ
ヴィンコヴィッチ,ムラデン
オレシック,マリナ
メストロヴィッチ,エルネスト
ダニロフスキー,アレクサンダー
ダムボヴィッチ,アロイズ
クネツェヴィッチ,ズドラフカ
ラザレフスキー,ゴリアナ
シンシック,ドミニク
フィリック,ダルコ
ラザリック,カティカ
ブカール,デヤン−クレシミール
Original Assignee
プリバ−イストラジヴァッキ・インスティテュート・ディーオーオー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by プリバ−イストラジヴァッキ・インスティテュート・ディーオーオー filed Critical プリバ−イストラジヴァッキ・インスティテュート・ディーオーオー
Publication of JP2005529082A publication Critical patent/JP2005529082A/ja
Publication of JP2005529082A5 publication Critical patent/JP2005529082A5/ja
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Finger-Pressure Massage (AREA)
  • Instructional Devices (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thermal Transfer Or Thermal Recording In General (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
JP2003575884A 2002-03-18 2003-03-18 9−デオキソ−9a−アザ−9a−メチル−9a−ホモエリスロマイシンA等構造擬似多形 Abandoned JP2005529082A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
HR20020231A HRP20020231A2 (en) 2002-03-18 2002-03-18 ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
US39361202P 2002-07-03 2002-07-03
US39470502P 2002-07-08 2002-07-08
PCT/IB2003/000987 WO2003077830A2 (en) 2002-03-18 2003-03-18 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives

Publications (2)

Publication Number Publication Date
JP2005529082A true JP2005529082A (ja) 2005-09-29
JP2005529082A5 JP2005529082A5 (cg-RX-API-DMAC10.html) 2006-04-06

Family

ID=28045976

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003575884A Abandoned JP2005529082A (ja) 2002-03-18 2003-03-18 9−デオキソ−9a−アザ−9a−メチル−9a−ホモエリスロマイシンA等構造擬似多形

Country Status (23)

Country Link
US (1) US7569549B2 (cg-RX-API-DMAC10.html)
EP (2) EP1627883A1 (cg-RX-API-DMAC10.html)
JP (1) JP2005529082A (cg-RX-API-DMAC10.html)
KR (1) KR20050002872A (cg-RX-API-DMAC10.html)
CN (1) CN1642966A (cg-RX-API-DMAC10.html)
AT (1) ATE440104T1 (cg-RX-API-DMAC10.html)
AU (1) AU2003215779A1 (cg-RX-API-DMAC10.html)
BG (1) BG108874A (cg-RX-API-DMAC10.html)
BR (1) BR0308644A (cg-RX-API-DMAC10.html)
CA (1) CA2479211A1 (cg-RX-API-DMAC10.html)
DE (1) DE60328872D1 (cg-RX-API-DMAC10.html)
EA (1) EA200401217A1 (cg-RX-API-DMAC10.html)
ES (1) ES2331733T3 (cg-RX-API-DMAC10.html)
HR (2) HRP20020231A2 (cg-RX-API-DMAC10.html)
IL (1) IL163836A0 (cg-RX-API-DMAC10.html)
IS (1) IS7449A (cg-RX-API-DMAC10.html)
MX (1) MXPA04009009A (cg-RX-API-DMAC10.html)
NO (1) NO20044341L (cg-RX-API-DMAC10.html)
NZ (1) NZ535477A (cg-RX-API-DMAC10.html)
PL (1) PL372468A1 (cg-RX-API-DMAC10.html)
RS (1) RS82504A (cg-RX-API-DMAC10.html)
TN (1) TNSN04166A1 (cg-RX-API-DMAC10.html)
WO (1) WO2003077830A2 (cg-RX-API-DMAC10.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
HRP20020614A2 (en) 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
EP1648473B1 (en) 2003-07-24 2009-01-28 PLIVA HRVATSKA d.o.o. Single dose fast dissolving azithromycin
EP1878432A1 (en) * 2003-07-24 2008-01-16 Pliva - Research and Development Ltd. Single dose fast dissolving azithromycin
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
WO2005053651A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
RU2331410C2 (ru) * 2003-12-04 2008-08-20 Пфайзер Продактс Инк. Способ получения фармацевтических мультичастиц
JP2007513147A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 押し出し機を使用して、好ましくはポロキサマーとグリセリドを含有する多粒子結晶性医薬組成物を製造するための噴霧凝結方法
BRPI0417338A (pt) * 2003-12-04 2007-04-17 Pfizer Prod Inc formas de dosagem de azitromicina multiparticulada por processos a base de lìquido
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
MX12213A (es) * 1987-07-09 1993-05-01 Pfizer Metodo de preparacion de dihidrato de azitromicina cristalino
HRP20020231A2 (en) 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
WO1994026758A1 (en) 1993-05-19 1994-11-24 Pfizer Inc. Intermediate for azithromycin
HRP940251B1 (en) 1994-04-15 1998-12-31 Stjepan Mutak Process for the preparation of azithromycin dihydrochloride
ES2122905B1 (es) * 1996-07-11 1999-11-16 Astur Pharma Sa Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
PT102130A (pt) 1998-03-13 1999-09-30 Hovione Sociedade Quimica S A Processo de preparacao de dihidrato de azitromicina
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
CN1205338A (zh) 1998-05-08 1999-01-20 刘万忠 阿奇霉素水溶性盐的合成新方法及其在医药上的用途
US6245903B1 (en) 1998-08-21 2001-06-12 Apotex, Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
US6365574B2 (en) * 1998-11-30 2002-04-02 Teva Pharmaceutical Industries Ltd. Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
US6703372B1 (en) * 1999-06-29 2004-03-09 Biochemie S.A. Macrolides
ES2177373B1 (es) * 1999-11-26 2003-11-01 Astur Pharma Sa Preparacion de azitromicina en su forma no cristalina
CA2396426A1 (en) 2000-01-04 2001-07-12 Teva Pharmaceutical Industries Ltd. Preparation method of azithromycin dihydrate
ES2162764B1 (es) * 2000-05-17 2003-04-01 Ercros Ind Sa Forma polimorfica del dihidrato de azitromicina, y su procedimiento deobtencion.
ES2260047T3 (es) * 2000-07-25 2006-11-01 Laboratorio Silanes, S.A. De C.V. Proceso de etapa unica para la preparacion de 7,16-deoxi-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihidroxi-6-etil-3,5,9,11,13,15-hexametilbiciclo(11.2.1)hexadeca-1(2)-en-ona y obtencion de una forma nueva de 9-deoxo-9a-metil-9a-homoeritromicina a.
AU2001280000A1 (en) 2000-08-23 2002-03-04 Jaweed Mukarram, Siddiqui Mohammed Process for preparation of anhydrous azithromycin
HU229488B1 (hu) * 2000-11-27 2014-01-28 Sandoz Ag Eljárás makrolid hidrátok elõállítására
KR100491183B1 (ko) 2001-03-21 2005-05-25 한미약품 주식회사 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
KR100431431B1 (ko) 2001-04-25 2004-05-14 한미약품 주식회사 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물
HRP20010301A2 (en) 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
DE60209704T2 (de) 2001-05-22 2006-11-16 Pfizer Products Inc., Groton Neue kristallforme von azithromycin
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
NZ532707A (en) 2001-12-21 2006-07-28 Pfizer Prod Inc Directly compressible formulations of azithromycin
NZ532063A (en) 2001-12-21 2006-03-31 Pfizer Prod Inc Methods for wet granulating azithromycin
MXPA04007427A (es) 2002-02-01 2004-10-11 Pfizer Prod Inc Formulaciones de azitromicina granuladas por via seca.
ITMI20021209A1 (it) 2002-06-04 2003-12-04 Chemi Spa Processo di preparazione di azitromicina ad elevata purezza

Also Published As

Publication number Publication date
US20040014951A1 (en) 2004-01-22
WO2003077830A3 (en) 2004-05-13
NO20044341L (no) 2004-11-23
HRP20020231A2 (en) 2003-12-31
EP1485393B1 (en) 2009-08-19
NZ535477A (en) 2006-11-30
AU2003215779A1 (en) 2003-09-29
RS82504A (sr) 2006-12-15
MXPA04009009A (es) 2005-06-17
TNSN04166A1 (en) 2007-03-12
KR20050002872A (ko) 2005-01-10
EP1627883A1 (en) 2006-02-22
CN1642966A (zh) 2005-07-20
EA200401217A1 (ru) 2005-02-24
CA2479211A1 (en) 2003-09-25
DE60328872D1 (en) 2009-10-01
US7569549B2 (en) 2009-08-04
HRP20040858A2 (en) 2005-06-30
EP1485393A2 (en) 2004-12-15
WO2003077830A2 (en) 2003-09-25
BR0308644A (pt) 2005-01-25
BG108874A (en) 2005-12-30
ATE440104T1 (de) 2009-09-15
IS7449A (is) 2004-09-16
PL372468A1 (en) 2005-07-25
IL163836A0 (en) 2005-12-18
ES2331733T3 (es) 2010-01-14

Similar Documents

Publication Publication Date Title
CN101573350B (zh) 甲磺酸伊马替尼的多晶型及其制备方法以及无定形和α型的甲磺酸伊马替尼
EP2181117B1 (en) Macrolide solid-state forms
JP2026047356A (ja) ベルモスジル及びベルモスジル塩の固体形態
CN112142679B (zh) 一种吉非替尼与香草酸共晶甲醇溶剂合物及其制备方法
US7569549B2 (en) Isostructural pseudopolymorphs of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A
CN105189513A (zh) 葡萄糖醇,1-脱氧-1-(甲胺基)-,1-(6-氨基-3,5-二氟吡啶-2-基)-8-氯-6-氟-1,4-二氢-7-(3-羟基氮杂环丁烷-l-基)-4-氧-3-喹啉羧酸盐的结晶形态
US6936591B2 (en) Amorphous 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A, process for preparing the same, and uses thereof
EP4509508A1 (en) Free-state plx5622 crystal form and preparation method therefor
JP2009513683A (ja) 抗生物質である結晶フシジン酸の調製
CN112538123B (zh) 一种舒更葡糖钠晶型m
JP2013184902A (ja) リファキシミン含有結晶
EP2882435B1 (en) Pharmaceutical formulations containing 3-(4-cinnamyl-L-piperazinyl) amino derivatives of 3-formylrifamycin S
US20060154953A1 (en) Amorphous tacrolimus and preparation thereof
CN100427499C (zh) 一种阿奇霉素的可溶性盐及其制备方法
WO2021216628A1 (en) Solid state forms of trifarotene and process for preparation thereof
WO2017015784A1 (zh) 奥比特嗪-富马酸盐、水合物、晶型及其制备方法
KR20160146428A (ko) 솔리페나신 또는 그의 약학적으로 허용되는 염과 락토즈를 포함하는 안정한 무정형 솔리페나신 약학 조성물 및 그의 제조방법
ZA200406971B (en) 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives.
JP4583601B2 (ja) 新規の6−デオキシエリスロマイシン誘導体、それらの製造方法及びそれらの薬剤としての使用
CN122036748A (zh) 苯并噁嗪噁唑烷酮类化合物otb-658的晶型iii及其制备方法和其组合物与用途
DE20321227U1 (de) Isostrukturelle Pseudopolymorphe von 9-Deoxo-9a-Aza-9a-Methyl-9a-Homoerythromycin A
CN121930247A (zh) 苯并噁嗪噁唑烷酮类化合物otb-658的晶型ii及其制备方法和其组合物与用途
JP2008523016A (ja) (5−アミノ−6−メトキシ−3−ピリジンカルボニル)カルバミン酸2−(s)−ヒドロキシムチリン14−エステルの新規の多形
EP4347564A1 (en) Solid state form of centanafadine hcl and process for preparation thereof
HK1247726B (en) Crystalline form of nicotinamide riboside

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20060112

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20060112

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060217

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060217

A762 Written abandonment of application

Free format text: JAPANESE INTERMEDIATE CODE: A762

Effective date: 20060928